2 More HCWs Survive Ebola After Receiving ZMapp; Small Study Shows Drug Effective Among Infected Lab Monkeys
News outlets report on two medical workers’ release from hospital after they were treated with ZMapp, an experimental drug, and cleared of the Ebola virus. Meanwhile, a small study shows the drug is effective among Ebola-infected lab monkeys.
Associated Press: Liberian Ebola survivor praises experimental drug
“A Liberian health worker who recovered from Ebola after receiving an experimental drug urged the manufacturer to speed up its production and send it to Africa, while crowds celebrated in the streets Saturday after authorities reopened a slum that had been barricaded for more than a week to try to contain the disease…” (Paye-Layleh, 8/30).
CNN: Two Liberian medical workers discharged after recovering from Ebola
“…Dr. Senga Omeonga and physician assistant Kynda Kobbah were discharged from a Liberian treatment center on Saturday after recovering from the virus, according to the World Health Organization. They were given ZMapp — the experimental drug that’s credited with saving the lives of two Americans infected with Ebola…” (Elbagir/Berlinger, 8/30).
New York Times: Experimental Drug Would Help Fight Ebola if Supply Increases, Study Finds
“A new study provides strong evidence that the experimental drug given to two American aid workers stricken with Ebola in Africa really works and could make a difference in the current outbreak — if more of it could be produced…” (Pollack, 8/29).
Reuters: Experimental Ebola drug ZMapp cures 100 percent of lab monkeys
“The experimental Ebola drug ZMapp cured all 18 of the lab monkeys infected with the deadly virus, including those suffering the fever and hemorrhaging characteristic of the disease and just hours from death, scientists reported on Friday…” (Begley, 8/30).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.